The global magnetic resonance imaging systems market size was valued at USD 7,004.15 million in 2024 and is projected to grow from USD 7,326.53 million in 2025 to USD 11,050.00 million by 2033, exhibiting a CAGR of 5.3% during the forecast period (2025-2033).
The major factors contributing to the growth of the global magnetic resonance imaging systems market include rapid technological integration, such as artificial intelligence (AI) into MRI systems in developed countries, increased field strength, and the emergence of helium-free systems. The AI integration in MRI systems has enhanced diagnostic precision and reduced scan times, boosting sales by 50%. Additionally, the expanding clinical applications of MRI in the diagnosis of chronic diseases such as cancer, cardiovascular conditions, and neurodegenerative disorders are further driving the need for MRI systems. Moreover, the use of portable and low-field MRI systems, the development of healthcare infrastructure, and increasing investment in public and private healthcare with an increasing geriatric population that are highly prone to chronic diseases requires the need for MRI scanning further propels the demand for MRI systems. Furthermore, increasing scanning volumes, advancements in radiomics, and the launch of advanced systems are enhancing imaging quality and speed, enabling broader adoption in outpatient and specialized care centers.
However, the growth of the market is restrained by notable factors such as High capital and operational costs in lower-income regions where funding is limited. The need for skilled radiologists and technologists is also a major challenge for the adoption of advanced MRI modalities. On the other hand, the market presents significant opportunities, such as innovations in helium-free technologies for middle income countries, lightweight MRI systems that are reducing installation and operational complexities.
The magnetic resonance imaging systems market is witnessing a significant transition from traditional hospital-based imaging services to outpatient imaging centers. This shift is driven by the growing emphasis on cost-efficiency, patient convenience, and faster turnaround times. Outpatient centers typically offer lower-cost imaging solutions while maintaining high diagnostic quality, making them increasingly attractive to both patients and payers.
This evolution not only reduces the burden on hospital infrastructure but also enhances accessibility for routine and elective imaging. As a result, the growing footprint of outpatient MRI centers is poised to reshape service delivery models, opening new growth avenues for imaging equipment manufacturers and service providers.
Traditional MRI machines require large volumes of liquid helium for cooling superconducting magnets, but the scarcity and rising cost of helium have made this model increasingly unsustainable. In response, manufacturers are developing next-generation MRI systems with zero or minimal helium dependency.
These advancements not only reduce installation and maintenance costs but also make MRI systems more accessible to facilities in remote or resource-limited settings. As the market embraces these helium-free innovations, it opens the door to broader global adoption, especially in emerging healthcare economies looking for reliable and environmentally responsible imaging solutions
To get more insights about this report Download Free Sample Report
The global expansion in the number of MRI scans is propelling the growth of the magnetic resonance imaging systems market, owing to rising awareness of early disease detection, improved diagnostic accuracy, and the expanding prevalence of chronic conditions such as cancer, neurological disorders, and musculoskeletal issues. Increasing number of MRI examinations in Canada signals the preference towards MRI as an imaging technique for disease diagnosis

Source: NHS England
This growth in MRI examinations not only in Canada and England but throughout the world is resulting into the need for the deployment maximum MRI systems across the globe, thereby propelling overall market expansion.
Magnetic resonance imaging is increasingly being adopted across a broader range of clinical specialties, significantly expanding its role in modern diagnostics and patient care. Originally focused on neurological and musculoskeletal imaging, MRI is now widely utilized in cardiology, breast cancer screening, liver imaging, and functional brain mapping, among other areas.
This broadening scope of clinical applications enhances the utility of MRI systems and drives greater demand from hospitals, specialty clinics, and diagnostic centers.
The widespread adoption of magnetic resonance imaging systems is limited with the high capital and operational cost. MRI machines, especially high-field and advanced models with functional or multi-parametric capabilities, often require investments ranging from hundreds of thousands to several million dollars. This expense not only includes the scanner itself but also extends to specialized shielding, installation, and ongoing maintenance.
As a result, despite growing diagnostic demand, the high cost continues to restrict market penetration in cost-sensitive regions and delays technology upgrades in underfunded hospitals, thereby tempering the overall growth potential of the MRI market.
The development of novel radiofrequency (RF) coils specifically designed for hyperpolarized MRI represents a cutting-edge potential in the market, aimed at remarkably enhancing image quality and functional imaging capabilities. Hyperpolarized MRI provides real-time metabolic information with exceptional clarity, particularly valuable in oncology, cardiology, and neurology.
As these innovations progress from research to clinical use, they are expected to unlock new diagnostic applications, thus expanding the technological scope and clinical utility of MRI systems in the years ahead.
North America, the dominant region with a 38.60% market share, accounted for the majority of the magnetic resonance imaging systems market revenue, owing to strong healthcare infrastructure, well-established reimbursement schemes, and increasing prevalence of chronic conditions such as neurodegenerative disorders and cancers. Additionally, high adoption of advanced MRI systems, strong presence of leading medical device companies, and robust diagnostic imaging infrastructure further drive market growth in the region. Further, collaboration between manufacturers and hospitals facilitate the flow towards exchange of expertise and exposure to recently developed systems is reshaping the diagnostic imaging capabilities in North America.

Source: World Intellectual Property Organization (WIPO)
Asia Pacific region is anticipated to grow at fastest CAGR during the forecast period. This growth is driven by rising prevalence of chronic conditions such as cancer and cardiovascular problems, improving healthcare infrastructure, increasing government initiatives, and growing investments in research for developing whole-body MRI. Additionally, expanding access to advanced diagnostic imaging in emerging economies such as China and India is accelerating market growth in the region. Further, expanding cancer screening efforts for breast, cervical, colorectal, stomach, and lung cancer in the region is increasing the deployment of advanced MRI systems across the region.
Such innovation was led by researchers from the Shenzhen Institute of Advanced Technology, part of the Chinese Academy of Sciences (SIAT).
Such expansion along with increasing prevalence of chronic diseases reflects growing public investment in healthcare, which is expected to drive demand for advanced imaging technologies such as MRI to enhance diagnostic capacity and support broader healthcare delivery across urban and rural regions.
Thus, high burden of brain disorders along with increasing number MRI scans throughout the country propels the demand for MRI devices for accurate diagnosis and monitoring of the condition.
Such integrated approach advances high-resolution imaging systems in France, which drives innovation and improves paediatric healthcare outcomes.
Such initiatives support the operational readiness of healthcare facilities, improve access to skilled radiographers, and create favorable conditions for wider deployment and adoption of MRI systems across the country.
The market is segmented into open systems and closed systems. Closed systems segment accounted for largest magnetic resonance imaging systems market share, owing to owing to their higher image resolution and superior diagnostic capabilities compared to open MRI systems. These systems offer stronger magnetic fields, enabling more detailed and accurate visualization of internal organs and tissues. Despite some discomfort issues for claustrophobic patients, their widespread use in hospitals and diagnostic centers for complex imaging, especially in neurology and oncology has contributed to their continued market leadership.
The market is segmented into ultra high, high and low. High segment dominated the magnetic resonance imaging systems sector. This growth is driven by widely adoption of 1.5T-3T MRI systems for routine clinical applications and provide excellent image resolution for neurological, cardiovascular, and musculoskeletal imaging. Their versatility and cost-efficiency have made them a preferred choice for both advanced hospitals and mid-tier imaging facilities, contributing to their strong market position.
The market is segmented into neurology, oncology, cardiology, musculoskeletal diseases, gastrointestinal diseases and others. Oncology segment is anticipated to register fastest CAGR during the forecast period owing to rising global cancer burden and increasing use of MRI in cancer diagnosis, staging, and treatment monitoring. MRI's non-invasive and radiation-free imaging capability makes it particularly valuable in identifying soft tissue tumors and assessing metastasis. The growing emphasis on early detection and precision oncology, along with increasing investments in cancer research and screening programs, is driving the rapid expansion of this segment.
The market is segmented into hospitals, imaging centers and others. Hospitals segment is anticipated to register fastest CAGR during the forecast period owing increasing deployment of MRI systems in hospitals for instance, 68.1% of total MRI systems installed in hospitals in U.S., In addition, government investments for installation of new MRI systems, growing demand for hospital-based medical imaging procedures, and demand for new MRI systems in hospitals is further fueling the segment growth.
Companies in the industry are focus on adopting key business strategies, such as product launches, acquisitions, and product approvals, to gain a strong foothold in the market.
FUJIFILM Holdings Corporation. is an emerging company in the market, owing to its advanced MRI systems portfolio and expanding market presence.
Recent developments
To get more findings about this report Download Market Share
The magnetic resonance imaging systems market is experiencing robust growth globally, driven by rising chronic disease prevalence, expanding applications of MRI systems, and continuous innovation in field strength of MRI systems. Governments and private sectors are heavily investing in research and development, fueling the development of advanced MRI systems. Additionally, improved field strength, increasing patient awareness, and rising MRI scans for early detection are accelerating MRI systems deployment globally.
| Report Metric | Details |
|---|---|
| Market Size in 2024 | USD 7,004.15 Million |
| Market Size in 2025 | USD 7,326.53 Million |
| Market Size in 2033 | USD 11,050.00 Million |
| CAGR | 5.3% (2025-2033) |
| Base Year for Estimation | 2024 |
| Historical Data | 2021-2023 |
| Forecast Period | 2025-2033 |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
| Segments Covered | By Type, By Field Strength, By Application, By End User, By Region. |
| Geographies Covered | North America, Europe, APAC, Middle East and Africa, LATAM, |
| Countries Covered | U.S., Canada, U.K., Germany, France, Spain, Italy, Russia, Nordic, Benelux, China, Korea, Japan, India, Australia, Taiwan, South East Asia, UAE, Turkey, Saudi Arabia, South Africa, Egypt, Nigeria, Brazil, Mexico, Argentina, Chile, Colombia, |
Explore more data points, trends and opportunities Download Free Sample Report
Jay Mehta is a Research Analyst with over 4 years of experience in the Medical Devices industry. His expertise spans market sizing, technology assessment, and competitive analysis. Jay’s research supports manufacturers, investors, and healthcare providers in understanding device innovations, regulatory landscapes, and emerging market opportunities worldwide.
Speak To AnalystAvailable for purchase with detailed segment data, forecasts, and regional insights.
Get This Report